NEWS
LifeArc appoints new Chief Investment Officer (CIO)

Graham Duce appointed to the newly created role of CIO to ensure that we have a sustainable approach to income generation.

Are you a scientist wanting to transition into the field of technology transfer? Apply for one of our Technology Tr… https://t.co/qkRkgDjgJ7
  • All
  • News Releases
  • Articles & blogs
  • Announcements
  • Events
    • News Releases
    10 January 2020
    LifeArc appoints new Chief Investment Officer (CIO)
    News Releases
    21 October 2019
    Patients with ultra-rare bone marrow disease set to benefit from £1.15m grant from LifeArc and The Aplastic Anaemia Trust
    News Releases
    29 August 2019
    LifeArc Seed Fund makes £1.5million investment in Caldan Therapeutics to develop novel treatments for metabolic diseases
    News Releases
    24 June 2019
    Kymab and LifeArc enter strategic partnership to discover new medicines using Kymab’s IntelliSelect® technologies
    News Releases
    14 June 2019
    LifeArc invests £1.5 million in Ducentis BioTherapeutics
    News Releases
    20 May 2019
    LifeArc monetises Keytruda® royalty interests to fund further research and investment
    News Releases
    9 May 2019
    Medicines Discovery Catapult and LifeArc launch strategic R&D partnership in biomarker discovery and proteomics technology
    News Releases
    24 April 2019
    LifeArc and The University of Kent collaborate to develop potential pain medicines
    News Releases
    16 April 2019
    LifeArc licenses lead stage molecules to Daiichi Sankyo